High Glucose Induces Sumoylation of Smad4 Via SUMO2/3 in Mesangial Cells

Xueqin Zhou,Chenlin Gao,Wei Huang,Maojun Yang,Guo Chen,Lan Jiang,Fang Gou,Hong Feng,Na Ai,Yong Xu
DOI: https://doi.org/10.1155/2014/782625
2014-01-01
BioMed Research International
Abstract:Recent studies have shown that sumoylation is a posttranslational modification involved in regulation of the transforming growth factor- β (TGF- β ) signaling pathway, which plays a critical role in renal fibrosis in diabetic nephropathy (DN). However, the role of sumoylation in the regulation of TGF- β signaling in DN is still unclear. In the present study, we investigated the expression of SUMO (SUMO1 and SUMO2/3) and Smad4 and the interaction between SUMO and Smad4 in cultured rat mesangial cells induced by high glucose. We found that SUMO1 and SUMO2/3 expression was significantly increased in the high glucose groups compared to the normal groupP<0.05. Smad4 and fibronectin (FN) levels were also increased in the high glucose groups in a dose-dependent manner. Coimmunoprecipitation and confocal laser scanning revealed that Smad4 interacted and colocalized with SUMO2/3, but not with SUMO1 in mesangial cells. Sumoylation (SUMO2/3) of Smad4 under high glucose condition was strongly enhanced compared to normal controlP<0.05. These results suggest that high glucose may activate TGF- β /Smad signaling through sumoylation of Samd4 by SUMO2/3 in mesangial cells.
What problem does this paper attempt to address?